Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
暂无分享，去创建一个
J. Schneider | M. Zeier | A. Hamann | P. Nawroth | A. Bierhaus | M. Morcos | K. Dugi | G. Rudofsky | F. Bozorgmehr | V. Schwenger | P. Humpert | A. Schlotterer | F. Pfisterer | G. Kukudov | B. Yard | Y. Ibrahim | F. van der Woude | A. A. Sayed | D. Oikomonou | R. Kientsch-Engels | F. J. van der Woude